Comparing Mercurius Solubilis And Constitutional Homeopathic Medicine For Treating Bad Breath

To Assess The Efficacy Of Mercurius Solubilis Vis A Vis Constitutional Homeopathic Medicine In Management Of Halitosis: A Prospective Single Blind RCT - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094988

Enrollment

Registered

2025-09-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R196- Halitosis

Interventions

Intervention1: Mercurius solubilis 30C: Dose- Mercurius Solubilis 30C potency, twice daily (BD), Rout of administration-Orally for a period of 28 days. (Group A) will consist of 52: Mercurius Solubi

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 to 40 years. Diagnosed with Organoleptic scale and genuine halitosis based on clinical examination (sniff test) and halimeter. Duration of symptoms more than one month. Willing to provide written informed consent. Available for the duration of study and follow-up.

Exclusion criteria

Exclusion criteria: Pseudo-halitosis or halitophobia. Halitosis due to known systemic diseases like uncontrolled diabetes, hepatic or renal failure. History of recent dental procedures (within 1 month). Use of antibiotics, antiseptic mouthwash, or probiotics within 2 weeks. Known hypersensitivity to mercury compounds. Pregnant and lactating women. Mentally incapacitated individuals.

Design outcomes

Primary

Measure	Time frame
1. To assess the improvement of halitosis by using Mercurius Solubilis. 2. To assess the effectiveness of constitutional homeopathic medicines in improving halitosis in cases that are not relieved by Mercurius Solubilis. 3. To evaluate and compare the efficacy of Mercurius Solubilis and constitutional homoeopathic medicine in reducing the severity of halitosis in patients aged 18 40 years. Timepoint: Follow-up is taken after 14 days of the medicine prescribed.for the Period of 3 months. The improvement in the follow up will be assessed based on the details of Organoleptic scale and halimeter.(halimeter range -more than 200 ppb) The second prescription will be based on the results of the follow up	—

Measure

Time frame

1. To assess the improvement of halitosis by using Mercurius Solubilis. 2. To assess the effectiveness of constitutional homeopathic medicines in improving halitosis in cases that are not relieved by Mercurius Solubilis. 3. To evaluate and compare the efficacy of Mercurius Solubilis and constitutional homoeopathic medicine in reducing the severity of halitosis in patients aged 18 40 years. Timepoint: Follow-up is taken after 14 days of the medicine prescribed.for the Period of 3 months. The improvement in the follow up will be assessed based on the details of Organoleptic scale and halimeter.(halimeter range -more than 200 ppb) The second prescription will be based on the results of the follow up

—

Secondary

Measure	Time frame
1.To reduce the social embarrassment caused to reduce the halitosis. 2. To assess the patient-reported symptoms using validated tools, such as organoleptic scores. 3. To minimize the complaints of halitosis in frequency of oral infection, foul breath other symptoms related to the oral cavities.Timepoint: Follow-up is taken after 14 days of the medicine prescribed. for the period of 3 months The improvement in the follow up will be assessed based on the details of Organoleptic scale & halimeter.(halimeter range -more than 200 ppb) The second prescription will be based on the results of the follow up	—

Measure

Time frame

1.To reduce the social embarrassment caused to reduce the halitosis. 2. To assess the patient-reported symptoms using validated tools, such as organoleptic scores. 3. To minimize the complaints of halitosis in frequency of oral infection, foul breath other symptoms related to the oral cavities.Timepoint: Follow-up is taken after 14 days of the medicine prescribed. for the period of 3 months The improvement in the follow up will be assessed based on the details of Organoleptic scale & halimeter.(halimeter range -more than 200 ppb) The second prescription will be based on the results of the follow up

—

Countries

India

Contacts

Public ContactDr Neha V Jadhavrao

Bharati Vidyapeeth Deemed to be University Homoeopathic Medical College and Hospital

neha.jadhavrao@bharatividyapeeth.edu9923003441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026